Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ADPT | HAE |
|---|---|---|
| Price | $29.84 | $104.68 |
| Change today | ▲ 5.26% | ▲ 0.00% |
| Market cap | $4.76B | $4.76B |
| Return, 3 months | +43.3% | +39.8% |
| Return, year to date | +83.7% | +30.6% |
| Return, 1 year | +106.2% | +111.3% |
| P/E (TTM) | -74.6 | 50.6 |
| P/B | 33.3 | 5.7 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.5% | -2.0% |
| Net profit growth (YoY) | -56.1% | -42.0% |
| Gross margin | 75.6% | 59.0% |
| Operating margin | -12.2% | 18.1% |
| Net margin | -20.7% | 7.1% |
| Return on equity | -39.6% | 11.2% |
| Analyst target vs. price | +2.5% | +11.5% |
| Analyst buy share | 100% | 86% |
| RSI (14) | 65 | 54 |
| 30-day volatility | 46.1% | 17.3% |
| Max drawdown, 1 year | -39.3% | -40.1% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
